The desired features of pharmaceutical drug delivery systems (DDS) for的简体中文翻译

The desired features of pharmaceuti

The desired features of pharmaceutical drug delivery systems (DDS) for parenteral (itravenous)administration include their small size, biodegradability, high content of a drug in a final preparation,prolonged circulation in the blood, and, ideally, the ability to target required areas passively (via theenhanced permeability and retention-EPR-effect) or actively (via specific ligands, such as monoclonalantibodies). While these requirements are reasonably well met by a variety of DDS (liposomes,microcapsules, nanoparticles) for water-soluble drugs, the development of nanoparticulate DDSdisplaying all of these properties for poorly soluble pharmaceuticals still represents a challenge.'Low solubility in water, however, tends to be an intrinsic property of many drugs, including powerfulanti-cancer agents. This is not surprising, since the membrane permeability and efficacy of variousdrugs increase with increasing hydrophobicity.At the same time, intravenous administration of those
0/5000
源语言: -
目标语言: -
结果 (简体中文) 1: [复制]
复制成功!
肠胃外(静脉)给药的药物递送系统(DDS)的所需功能包括其体积小,可生物降解性,最终制剂中药物的含量高,血液循环延长以及理想地靶向所需区域的能力被动地(通过增强的渗透性和保留-EPR效应)或主动地(通过特定的配体,例如单克隆抗体)。尽管各种水溶性药物的DDS(脂质体,微胶囊,纳米颗粒)可以合理地满足这些要求,但开发出显示难溶性药物所有这些特性的纳米颗粒DDS仍然是一个挑战。往往是许多药物的内在特性,包括强大的抗癌药。这不足为奇
正在翻译中..
结果 (简体中文) 2:[复制]
复制成功!
The desired features of pharmaceutical drug delivery systems (DDS) for parenteral (itravenous)administration include their small size, biodegradability, high content of a drug in a final preparation,prolonged circulation in the blood, and, ideally, the ability to target required areas passively (via theenhanced permeability and retention-EPR-effect) or actively (via specific ligands, such as monoclonalantibodies). While these requirements are reasonably well met by a variety of DDS (liposomes,microcapsules, nanoparticles) for water-soluble drugs, the development of nanoparticulate DDSdisplaying all of these properties for poorly soluble pharmaceuticals still represents a challenge.'Low solubility in water, however, tends to be an intrinsic property of many drugs, including powerfulanti-cancer agents. This is not surprising, since the membrane permeability and efficacy of variousdrugs increase with increasing hydrophobicity.At the same time, intravenous administration of those
正在翻译中..
结果 (简体中文) 3:[复制]
复制成功!
用于肠外(itravenous)给药的药物输送系统(DDS)的理想特性包括其体积小、可生物降解、最终制剂中药物含量高、在血液中循环时间长,并且理想情况下,被动(通过增强的渗透性和保留EPR效应)或主动(通过特定配体,如单克隆丙酮体)靶向所需区域的能力。虽然水溶性药物的各种DDS(脂质体、微胶囊、纳米颗粒)都能很好地满足这些要求,但开发出具有难溶性药物所有这些特性的纳米颗粒DDS仍然是一个挑战。然而,水溶性低往往是许多药物的固有特性药物,包括强力抗癌药。这并不奇怪,因为各种药物的膜透性和疗效都随着增加而增加疏水性同时,静脉注射<br>
正在翻译中..
 
其它语言
本翻译工具支持: 世界语, 丹麦语, 乌克兰语, 乌兹别克语, 乌尔都语, 亚美尼亚语, 伊博语, 俄语, 保加利亚语, 信德语, 修纳语, 僧伽罗语, 克林贡语, 克罗地亚语, 冰岛语, 加利西亚语, 加泰罗尼亚语, 匈牙利语, 南非祖鲁语, 南非科萨语, 卡纳达语, 卢旺达语, 卢森堡语, 印地语, 印尼巽他语, 印尼爪哇语, 印尼语, 古吉拉特语, 吉尔吉斯语, 哈萨克语, 土库曼语, 土耳其语, 塔吉克语, 塞尔维亚语, 塞索托语, 夏威夷语, 奥利亚语, 威尔士语, 孟加拉语, 宿务语, 尼泊尔语, 巴斯克语, 布尔语(南非荷兰语), 希伯来语, 希腊语, 库尔德语, 弗里西语, 德语, 意大利语, 意第绪语, 拉丁语, 拉脱维亚语, 挪威语, 捷克语, 斯洛伐克语, 斯洛文尼亚语, 斯瓦希里语, 旁遮普语, 日语, 普什图语, 格鲁吉亚语, 毛利语, 法语, 波兰语, 波斯尼亚语, 波斯语, 泰卢固语, 泰米尔语, 泰语, 海地克里奥尔语, 爱尔兰语, 爱沙尼亚语, 瑞典语, 白俄罗斯语, 科西嘉语, 立陶宛语, 简体中文, 索马里语, 繁体中文, 约鲁巴语, 维吾尔语, 缅甸语, 罗马尼亚语, 老挝语, 自动识别, 芬兰语, 苏格兰盖尔语, 苗语, 英语, 荷兰语, 菲律宾语, 萨摩亚语, 葡萄牙语, 蒙古语, 西班牙语, 豪萨语, 越南语, 阿塞拜疆语, 阿姆哈拉语, 阿尔巴尼亚语, 阿拉伯语, 鞑靼语, 韩语, 马其顿语, 马尔加什语, 马拉地语, 马拉雅拉姆语, 马来语, 马耳他语, 高棉语, 齐切瓦语, 等语言的翻译.

Copyright ©2024 I Love Translation. All reserved.

E-mail: